Momentive Technologies and Stevanato Group Collaborate to Offer Pur Q Fused Quartz Vials in EZ-fill Configuration

Agreement delivers high-purity quartz vials in efficient secondary packaging format to streamline fill-finish operations for early phase drug development.

Momentive Technologies–a company providing high-purity quartz products for high-quality processing and production for applications in a wide range of industries–and Stevanato Group–a privately-owned designer and producer of glass primary packaging for the pharmaceutical industry–announce a collaboration agreement to supply Momentive Technologies’ Pur Q fused quartz vials in the Stevanato Group’s EZ-fill packaging format.

The Pur Q vials are the first fused quartz vials available for pharmaceutical packaging. Stevanato Group’s EZ-fill secondary packaging system provides a fully integrated, ready-to-use system for aseptic fill-finish operations. Combined, the offerings will help biopharmaceutical companies improve the reliability and speed of drug development and production of lifesaving medications via stable primary packaging and an efficient secondary packaging method.

Momentive Technologies designed the Pur Q vial as a high-purity system for drug storage and delivery. Made from 99.995% pure silicon dioxide (SiO2), the fused quartz vials are made to have an inert, nonreactive surface to reduce risk of interaction with packaged drug formulations.

“Providing our vials to the market in this ready-to-use format allows the industry to screen early stage drug formulations and simply scale up to full production, without changing the container or filling process. Due to the vials’ highly inert properties, biopharmaceutical companies will be able to confidently take the container out of the equation when assessing the viability of formulations, helping to accelerate the development of increasingly complex and sensitive biologic drug formulations,” says Robert Koch, global commercial director at Momentive Technologies.

Stevanato Group designed its EZ-fill secondary packaging to mitigate the risk of breakages, cosmetic issues, and particulate generation during fill-finish operations. The packaging stores vials safely in a tray, or nest and tub configuration for efficient filling, while minimizing glass-to-glass contact. From lab-scale manual filling up to the traditional filling process, this system is designed to enable the accelerated development and widespread commercialization of innovative, lifesaving pharmaceutical and biologic treatments.

“Biopharma companies can now count on an additional robust primary packaging option that complements our ready-to-use secondary packaging solution to enable lean manufacturing, production flexibility, and ease of use,” said Fabio Bertacchini, director of Product Management at Stevanato Group.

More in Supplier News